Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Fish and Richardson
Baxter
Healthtrust
Dow
Merck
Covington
UBS
Queensland Health

Generated: July 19, 2018

DrugPatentWatch Database Preview

Prednisolone acetate; sulfacetamide sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for prednisolone acetate; sulfacetamide sodium and what is the scope of prednisolone acetate; sulfacetamide sodium patent protection?

Prednisolone acetate; sulfacetamide sodium
is the generic ingredient in ten branded drugs marketed by Allergan, Alcon, Schering, Pharmafair, Novartis, Akorn, and Bausch And Lomb, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-seven drug master file entries for prednisolone acetate; sulfacetamide sodium. Two suppliers are listed for this compound.
Summary for prednisolone acetate; sulfacetamide sodium
US Patents:0
Tradenames:10
Applicants:7
NDAs:11
Drug Master File Entries: 87
Suppliers / Packagers: 2
DailyMed Link:prednisolone acetate; sulfacetamide sodium at DailyMed
Pharmacology for prednisolone acetate; sulfacetamide sodium

US Patents and Regulatory Information for prednisolone acetate; sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair PREDSULFAIR II prednisolone acetate; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 088837-001 Dec 24, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair PREDSULFAIR prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 088032-001 Apr 15, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Allergan BLEPHAMIDE prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 012813-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alcon ISOPTO CETAPRED prednisolone acetate; sulfacetamide sodium SUSPENSION;OPHTHALMIC 087547-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
AstraZeneca
Boehringer Ingelheim
Harvard Business School
Deloitte
US Army
Daiichi Sankyo
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.